NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 Gallery NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 By Chloe Atkinson|2025-08-05T10:23:46+00:00April 28th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Results Summary Available Gallery NG11-2 Phase-Ib Clinical Study Results Summary Available By Chloe Atkinson|2025-06-09T09:17:16+00:00March 5th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Report Complete Gallery NG11-2 Phase-Ib Clinical Study Report Complete By Chloe Atkinson|2025-05-20T09:41:22+00:00January 20th, 2025|News| Read More
New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 Gallery New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 By Chloe Atkinson|2025-01-03T10:10:53+00:00January 2nd, 2025|News| Read More
VasoDynamics Receives UK-Taiwan Collaborative R&D Grant Gallery VasoDynamics Receives UK-Taiwan Collaborative R&D Grant By Chloe Atkinson|2025-08-05T10:48:31+00:00November 25th, 2024|News| Read More
VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme Gallery VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme By Chloe Atkinson|2024-11-13T12:56:20+00:00October 18th, 2024|Clinical Development, News, NG11| Read More
VasoDynamics strengthens the Board with key appointments Gallery VasoDynamics strengthens the Board with key appointments By Chloe Atkinson|2024-12-05T11:08:04+00:00September 2nd, 2024|Corporate Development, News| Read More
NG11-2 Phase-Ib Study Completes Last Patient Visit Gallery NG11-2 Phase-Ib Study Completes Last Patient Visit By Chloe Atkinson|2024-11-13T12:57:16+00:00August 21st, 2024|Clinical Development, News, NG11| Read More
NG11-2 Phase-Ib Study Closes Enrolment – Results Expected Autumn 2024 Gallery NG11-2 Phase-Ib Study Closes Enrolment – Results Expected Autumn 2024 By Chloe Atkinson|2024-11-13T12:57:26+00:00July 1st, 2024|Clinical Development, News, NG11| Read More
VasoDynamics Presents Phase-1b NG11-2 Clinical Data at ESTRO Conference Gallery VasoDynamics Presents Phase-1b NG11-2 Clinical Data at ESTRO Conference By Chloe Atkinson|2025-08-05T11:07:01+00:00May 9th, 2024|Clinical Development, News, NG11| Read More
